Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories

Joshua A. Lieberman, Gregory Pepper, Samia N. Naccache, Meei-Li Huang, Keith R. Jerome, Alexander L. Greninger
doi: https://doi.org/10.1101/2020.04.24.20074559

Article usage

Article usage: April 2020 to September 2023

AbstractFullPdf
Apr 202017880536
May 20209830429
Jun 20204000226
Jul 20203500155
Aug 20202400107
Sep 2020144077
Oct 2020124046
Nov 202081040
Dec 202056429
Jan 202151120
Feb 202159212
Mar 202173320
Apr 202190019
May 202175319
Jun 202167315
Jul 202152120
Aug 202151517
Sep 202141112
Oct 202143340
Nov 202143447
Dec 202124023
Jan 202238513
Feb 20222615
Mar 20222338
Apr 20223028
May 202245116
Jun 20221934
Jul 20222302
Aug 20221714
Sep 20222618
Oct 20223609
Nov 20221609
Dec 20222016
Jan 202321013
Feb 20232349
Mar 2023906
Apr 202316112
May 202311113
Jun 202310411
Jul 2023708
Aug 2023161410
Sep 20231856
Back to top
Posted April 27, 2020.
Download PDF
Data/Code
Email
Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories
Joshua A. Lieberman, Gregory Pepper, Samia N. Naccache, Meei-Li Huang, Keith R. Jerome, Alexander L. Greninger
medRxiv 2020.04.24.20074559; doi: https://doi.org/10.1101/2020.04.24.20074559
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area